Clinical Trial Update: A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors. [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating multimodal ablation with systemic drug therapy for advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma
• Triple-negative Breast Cancer

Snippet

Sponsor: Fudan University | Conditions: Triple Negative Breast Cancer Metastatic, Melanoma Metastatic | Phase 2 | Status: RECRUITING